Moran Slavin, MD
@MoranSlavin
Followers
117
Following
7K
Media
3
Statuses
158
HPB & Upper GI surgical oncology, MIS advocate, surgical education enthusiast. Mother of three so no hobbies (;
New York, USA
Joined December 2020
The long awaited #DIPLOMA2
Is minimally invasive (robot) #Whipple surgery just as safe as open surgery? Today: #DIPLOMA2 RCT in @NEJMEvidence ➡️ https://t.co/amrQ7hTk4O 288 patients, 14 expert centers, 6 countries 🇳🇱🇮🇹🇩🇪🇧🇪🇪🇸🇸🇪): MIS equally safe as open in experienced centers. With faster recovery,
0
0
2
“Save the liver, you save a life”. Plus save some liver for later
The POSH technique for colorectal liver metastases offers a safe approach while resecting a high number of lesions, and maintaining a low rate of complications and 90-day mortality.
0
0
0
Proctoring is critical for the safe adoption of new operative tech/procedures. Are we doing it right? (A slide from my recent talk on the ethics of proctoring)
10
14
45
״Liver resection has an excellent oncologic effectiveness, even in patients with severe tumor burden״
In the context of evolving management options for colorectal liver metastases besides surgery, this study proposes standard reference values for oncologic treatments to serve as benchmarks when evaluating alternative treatments.
0
1
1
#Rise of the #Robots 🦾 in the Netherlands 🇳🇱 GI surgery @AnnalsofSurgery 😳 How does this compare to your country? Data? Nationwide use 🦾 per organ among 77,361 resections (2014-2023): ✅ pancreas 1% to 33% ✅ thoracic 3% to 11% ✅ colon 6% to 14% ✅ rectum 19% to 45% ✅
0
11
41
In #ClinicalTrial EA2222/PUMP, investigators are testing #PumpChemo in addition to SOC chemo versus SOC chemo alone for patients with unresectable #ColorectalCancer liver metastases. For more: https://t.co/xBChV6GALe cc : @michael_lidsky
0
4
5
Congratulations! @ColumbiaSurgery and @ClevelandClinic won!
Congratulations to our rising chief residents Drs. Murthy and Iqbal on their fellowship match today! Expect great things in transplant/HPB surgery from these two!! @CCFSurgery @ColumbiaSurgery @ClevelandClinic @nyphospital @EinsteinMed
0
0
5
Serum carbohydrate antigen 19-9 greater than 100 and risk of invasive carcinoma in pancreatic intraductal papillary mucinous neoplasms https://t.co/Sb4ssEyl9R superb @SurgJournal study by @motazqadan @servinrojasmd @rajarnarayan @ZhiVenFongMD @MGHSurgery @harvardmed @Harvard
1
9
40
🇨🇦 in #eahpba2025 champions league 🏆 HELIX RCT of TXA vs placebo for hepatectomy by @PaulKaranicolas No change in 🩸transfusion but ⬆️ morbidity with TXA ⚠️ don’t use TXA for hepatectomy See 📝 @JAMA_current 👉🏻 https://t.co/7MT7lv1nk9
2
21
48
Breaking news! Pump vs transplant is no longer a debate❤️. The parties (dr. Kingham and dr. Chapman) have come to agreement - transplant perfectly fits where #HAIP chemo fails. @villesallinen @graokane can be congratulated as peacemakers #eahpba2025 @xtofero @pdline
2
9
30
The struggle is real. And CD grade 3 is enough to ruin my day.
Early-career surgeons face high vulnerability to moral injury from complications and poor outcomes. Building “protective equity” through mentorship and peer support may mitigate long-term harm. https://t.co/A3VyYgtBMj
0
0
2
#ASCO2025 📢Practice changing for Biliary Tract and Gallbladder Cancers! GAIN trial Neoadjuvant chemo drastically improves outcomes in resectable BTC/GBC Phase III, randomized (N=68, stopped early due to accrual) Arm A: Gem/Cis ×3 → surgery → Gem/Cis ×3 Arm B: surgery →
10
48
144
Great time yesterday, talking about data on minimally invasive HPB surgery and program building at grand rounds @MontefioreSurg. Thanks for having me!
0
1
7
"It's not only the responsibility of MTB and general surgeons to include a LS in the treatment planning for patients with stage IV CRC, but also the obligation of the LS to effectively communicate and make themselves available"@AnnSurgOncol @AmCollSurgeons
2
6
20
Adjuvant chemotherapy compared to observation in resected biliary tract cancers: Survival meta-analysis of phase-III controlled trials European J Cancer https://t.co/Gk4jm3GH9R 👉4 trials: BILCAP, ASCOT, BCAT, PRODIGE-12 👉only ASCOT met 1° EP 🧐Not convincing, we need to do
3
43
96
Successful first two cases of #HAIP at @MontefioreNYC. Great team work #MECCC. Great support from @MontefioreSurg leadership. This essential component of contemporary multidisciplinary care for CRLM & IHC is now available in the Bronx.
0
2
18
Very true. Working towards change @MontefioreSurg surgical oncology and #MECCC
Despite the 'Hispanic Paradox,' hepatobiliary and gastric cancers are rising among Hispanic individuals 📈🏥. Late diagnoses and barriers to surgical care worsen outcomes. Surgeons have a role in closing these gaps. https://t.co/h696WgKKR3
1
1
3
An honor and a privilege. HAIP coming soon to the Bronx.
So honored to have Dr. Nancy Kemeny give the Blumgart Historical Lecture at #AHPBA2025 Inspiring to see the history and evolution of #HAI⛽️ tx for mCRC and #cholangiocarcinoma Amazed to see just a sample of the sheer # of Surg fellows trained in this life-saving 🎁 to pts.
0
0
3
Neoadjuvant chemotherapy for left 👈 sided resectable PDAC 🪡 72% of US received adjuvant 💉 NAT had better OS (53 🆚 37 months) 🤏 Tumor size and 🧪 elevated CA19.9 correlates with benefits of NAT And now… time for RCT! 💪 https://t.co/AgCYbVGrpt
1
20
69
1st line Systemic Treatment for Initially Unresectable CRC Liver Mets @JAMAOnc
https://t.co/dqMQ5ADCBW 🔎 Post Hoc of CAIRO5 Trial 👉no difference in OS between arms 👉excellent OS for pts w/ salvage local treatment in case of early recurrence @myESMO
1
24
75